Bevacizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BEVACIPTIN bevacizumab 100 mg/4 mL concentrated solution for infusion vial AUST R: 347292Active ingredients:
Bevacizumab
Dosage form:
Injection, concentrated
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
02 Aug 2024
to
30 Jun 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
BEVACIPTIN bevacizumab 400 mg/16 mL concentrated solution for infusion vial AUST R: 347293Active ingredients:
Bevacizumab
Dosage form:
Injection, concentrated
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
30 Apr 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|